Wishing you all the joys of the season! 
Middle East & Africa PCR Technologies Market Forecast to 2030
Middle East & Africa PCR Technologies Market Forecast to 2030 – Regional Analysis – by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Prevalence of Genetic and Infectious Diseases Bolsters Middle East & Africa PCR Technologies Market
According to the National Organization’s information on genetic conditions or congenital disabilities, genetic disorders are rare conditions, but they collectively comprise over 15,500 positive diagnoses every year. Estimates published in a report by MJH Life Sciences (US) in 2022 state that ~300,000 newborns are born with sickle cell disease (SCD) globally every year, accounting for ~5% of the global population. Further, as per the June 2020 report by Novartis AG, SCD affects around eight million individuals globally. Around 500 children die from SCD-related complications per day in Africa, where the disease has the highest burden. As a result of the rising incidence of SCDs, the adoption of digital polymerase chain reaction (dPCR) is increasing in pathology centers, wherein this technology is being exploited for targeting various DNA-specific sequences to confirm diagnoses and design various clinical tests. dPCR can target specific DNA sequences in just one molecule of DNA. This tool allows researchers to detect rare genetic mutations that are difficult to identify by using real-time PCR. The COVID-19 outbreak had a significant impact on the PCR technologies market. PCR is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations. The amplified DNA even serves as the basis for most next-generation sequencing (NGS) preparation. Nearly all diagnostic tests used real-time PCR for testing people having symptoms of COVID-19. Most of the biotech and pharmaceutical businesses shifted their focus toward research and development (R&D) divisions to find novel compounds or therapeutic approaches for COVID-19, which, in turn, benefitted the PCR technologies market. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the Cobas SARS-CoV-2 and influenza A/B tests, as well as the Cobas SARS-CoV-2 qualitative test. The product offers uniform performance and efficiency in low-, medium-, and high-volume molecular laboratory tests. Thus, the increasing incidence of genetic and infectious diseases supports the growth of the PCR technologies market.
Middle East & Africa PCR Technologies Market Overview
The Middle East & Africa PCR technologies market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience significant growth due to an increase in the development of varied reagent systems and automated systems in this region, a wide range of new products in diagnostic laboratories, and a growing number of conferences, meetings, workshops, and symposiums. Saudi Arabia is among the fastest-growing countries in the Middle East & Africa. Changing healthcare infrastructure through public-private partnerships between government and international players strengthens the country’s healthcare sector. These partnerships and privatization efforts align with the Saudi government’s “Vision 2030” policies to transform the national economy. As per the International Trade Administration, the Saudi Arabian government invested ~US$ 65 billion to build the country’s healthcare infrastructure as part of Vision 2030. Increased investment in infrastructure and innovation is anticipated to favor the market positively. PCR technologies have wide applications in the diagnosis of infectious diseases, oncology, autoimmune diseases, genetic diseases, HIV/AIDS, and others. It is used by medical practitioners in hospitals, laboratories, and other healthcare facilities and at various stages of the patient treatment process. Further, studies on DNA polymorphism, lung cancer, and colorectal cancer use dPCR and qPCR techniques to assess the mRNA expression of genes, boosting the PCR technologies market. Saudi Arabia has a growing number of genetic diseases due to consanguineous marriage, and thus, the increase in premarital genetic screening drives the market growth. The Government of Saudi Arabia has made it mandatory to undergo premarital genetic screening before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia, which are most prevalent in the country. Therefore, the rising prevalence of genetic diseases and increasing premarital genetic testing in Saudi Arabia drive the market growth. Also, the growing number of cancer cases has fueled cancer research in Saudi Arabia. As per Globocan 2020 data, the country recorded ~27,885 new cancer cases. The five-year prevalence rate for cancer in all ages was found to be 237.4 per 100,000 people, which, in turn, propels the demand for PCR technologies in Saudi Arabia.
Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa PCR Technologies Market Segmentation
The Middle East & Africa PCR technologies market is segmented into technology, offerings, application, end user, and country.
Based on technology, the Middle East & Africa PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Middle East & Africa PCR technologies market in 2022.
In terms of offerings, the Middle East & Africa PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Middle East & Africa PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
Based on application, the Middle East & Africa PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Middle East & Africa PCR technologies market in 2022.
Based on end user, the Middle East & Africa PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Middle East & Africa PCR technologies market in 2022.
By country, the Middle East & Africa PCR technologies market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa PCR technologies market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the Middle East & Africa PCR technologies market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the Middle East & Africa PCR technologies market was valued at US$ 626.35 million in 2022 and is expected to reach US$ 1,057.27 million by 2030, registering a CAGR of 6.8% from 2022 to 2030. Advancements in PCR technologies and funds availability for PCR technologies are among the critical factors attributed to the Middle East & Africa PCR technologies market expansion.
The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung’s research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes.
A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.
On the contrary, high costs of PCR systems and availability of alternative assay hampers the growth of Middle East & Africa PCR technologies market.
Based on technology, the Middle East & Africa PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held 38.7% share of Middle East & Africa PCR technologies market in 2022, amassing US$ 242.65 million. It is projected to garner US$ 428.59 million by 2030 to expand at 7.4% CAGR during 2022-2030.
In terms of offerings, the Middle East & Africa PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 59.5% share of Middle East & Africa PCR technologies market in 2022, amassing US$ 372.48 million. It is projected to garner US$ 666.83 million by 2030 to expand at 7.6% CAGR during 2022-2030. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
Based on application, the Middle East & Africa PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held 23.4% share of Middle East & Africa PCR technologies market in 2022, amassing US$ 146.53 million. It is projected to garner US$ 264.24 million by 2030 to expand at 7.6% CAGR during 2022-2030.
Based on end user, the Middle East & Africa PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held 56.9% share of Middle East & Africa PCR technologies market in 2022, amassing US$ 356.52 million. It is projected to garner US$ 622.26 million by 2030 to expand at 7.2% CAGR during 2022-2030.
By country, the Middle East & Africa PCR technologies market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 40.1% share of Middle East & Africa PCR technologies market in 2022. It was assessed at US$ 251.23 million in 2022 and is likely to hit US$ 417.76 million by 2030, exhibiting a CAGR of 6.6% during 2022-2030.
Key players operating in the Middle East & Africa PCR technologies market are Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd, among others.
In November 2023, Qiagen launched new kits for use on its QIAcuity systems and a major new software update designed to expand the portfolio of applications for use of digital PCR technology in areas like cell and gene therapies, DNA and RNA quantification, as well as food and pharmaceuticals safety.
In July 2023, QIAGEN announced the expansion of its digital PCR offering to develop cell and gene therapies in the biopharma industry. The company partnered with Niba Labs to offer biopharma customers customized digital PCR assay design services. Also, it launched the new CGT Viral Vector Lysis Kit that enables a standardized workflow from cell lysates to absolute and precise quantification of viral titers for multiple serotypes.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa PCR Technologies Market – Key Industry Dynamics
4.1 PCR Technologies Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market – Middle East & Africa Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 – 2030
6. Middle East & Africa PCR Technologies Market Analysis – By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa PCR Technologies Market Analysis – By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa PCR Technologies Market Analysis – By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa PCR Technologies Market Analysis – By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa PCR Technologies Market -Country Analysis
10.1 Middle East & Africa: PCR Technologies Market
10.1.1 Overview
10.1.2 Middle East & Africa PCR Technologies Market Revenue and Forecast and Analysis – By Country
10.1.2.1 Saudi Arabia
10.1.2.1.1 Overview
10.1.2.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
10.1.2.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
10.1.2.3 South Africa
10.1.2.3.1 Overview
10.1.2.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 South Africa PCR Technologies Market Breakdown by Technology
10.1.2.4.2 South Africa PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 South Africa PCR Technologies Market Breakdown by Application
10.1.2.4.4 South Africa PCR Technologies Market Breakdown by End User
10.1.2.5 United Arab Emirates
10.1.2.5.1 Overview
10.1.2.6 United Arab
10.1.2.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
10.1.2.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
10.1.2.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
10.1.2.7 Rest of Middle East & Africa
10.1.2.7.1 Overview
10.1.2.8 Rest of Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Rest of Middle East & Africa PCR Technologies Market Breakdown by Application
10.1.2.8.4 Rest of Middle East & Africa PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Ellume Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the the Reporting Teams
13.2 Glossary of Terms
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Technology
Table 3. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Offerings
Table 4. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
Table 5. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
Table 6. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
Table 7. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Application
Table 8. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By End User
Table 9. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 10. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 11. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 12. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 13. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 14. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 15. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 16. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 17. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 18. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 19. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 20. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 21. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 22. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 23. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 24. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 25. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 26. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 27. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 28. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 29. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 30. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 31. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 32. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 33. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 34. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 35. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 36. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 37. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 38. Recent Organic Growth Strategies in the PCR Technologies Market
Table 39. Glossary of Terms, PCR Technologies Market
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 – 2030
Figure 4. PCR Technologies Market Share (%) – By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) – By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) – By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) – By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Middle East & Africa: PCR Technologies Market, by Key Country – Revenue (2022) (US$ Million)
Figure 31. Middle East & Africa PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Saudi Arabia PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 33. South Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 34. United Arab Emirates PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 35. Rest of Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 36. Growth Strategies in the PCR Technologies Market
The List of Companies – Middle East & Africa PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Ellume Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.